These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7271865)

  • 1. Stereochemical aspects of the metabolism of phenprocoumon in rat liver microsomes.
    Wheeler C; Trager WF; Porter WR
    Biochem Pharmacol; 1981 Jul; 30(13):1785-90. PubMed ID: 7271865
    [No Abstract]   [Full Text] [Related]  

  • 2. 2-Acetylaminofluorene metabolism in rat liver microsomes: formation of 9-hydroxy-2-acetylaminofluorene and effect of hepatic enzyme modifiers.
    Son OS; Fowble JW; Miller DD; Feller DR
    Toxicol Appl Pharmacol; 1979 Nov; 51(2):367-77. PubMed ID: 43607
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro metabolism of a new 4-hydroxycoumarin anticoagulant. Structure of an unusual metabolite.
    Thonnart N; Vanhaelen M; Vanhaelen-Fastré R
    J Med Chem; 1977 Apr; 20(4):604-6. PubMed ID: 850251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inducers and/or inhibitors on metabolism of lysergic acid diethylamide in rat liver microsomes.
    Inoue T; Niwaguchi T; Murata T
    Xenobiotica; 1980 Dec; 10(12):913-20. PubMed ID: 7210704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the metabolic profiles of R- and S-warfarin and R- and S-phenprocoumon as a probe to categorize the effect of inducing agents on microsomal hydroxylases.
    Porter WR; Wheeler C; Trager WF
    Biochem Pharmacol; 1981 Nov; 30(22):3099-104. PubMed ID: 7337727
    [No Abstract]   [Full Text] [Related]  

  • 6. Liver microsomal metabolism of N-methylcarbazole: a probe for induction, inhibition, and species differences.
    Koop DR; Hollenberg PF
    Mol Pharmacol; 1980 Jan; 17(1):118-27. PubMed ID: 7383014
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic microsomal biotransformation of 1,3,5(10),16-estratetraen-3-o1 to 16,17-epiestriol and estriol via 16 alpha,17 alpha- and 16 beta,17 beta-epoxy-1,3,5(10)-estratrien-3-ols.
    Watabe T; Ichihara S; Sawahata T
    J Biol Chem; 1979 Nov; 254(21):10720-7. PubMed ID: 500607
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of cytochrome P-450 in mixed function oxidation and metabolism of anesthetics].
    Shigematsu A; Takahashi S; Furukawa T
    Masui; 1974 Feb; 23(2):89-98. PubMed ID: 4603810
    [No Abstract]   [Full Text] [Related]  

  • 9. Rat hepatic microsomal metabolism of oxyprothepine: the role of inhibitors on S-oxygenation.
    Pauliková I; Helia O
    Pharmazie; 1992 Jan; 47(1):64. PubMed ID: 1351685
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of inhibitors on drug metabolism.
    Netter KJ
    Drug Metab Dispos; 1973; 1(1):162-3. PubMed ID: 4149378
    [No Abstract]   [Full Text] [Related]  

  • 11. Aflaxation B1 hydroxylation by hepatic microsomal preparations from the rhesus monkey.
    Krieger RI; Salhab AS; Dalezios JI; Hsieh DP
    Food Cosmet Toxicol; 1975 Apr; 13(2):211-9. PubMed ID: 236980
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cholestyramine interrupts the enterohepatic circulation of phenprocoumon: a new therapeutic possibility in the treatment of phenprocoumon overdose].
    Meinertz T; Jähnchen E; Gilfrich HJ; Groth U; Jonen HG
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1582-4. PubMed ID: 347787
    [No Abstract]   [Full Text] [Related]  

  • 13. Microsomal metabolism of arylamides by the rat and guinea pig--II. Oxidation of 3-fluorenylacetamide at carbon atom 9. Formation of 3-acetamido-9-fluorenone.
    Kaplan E; Gutmann HR
    Biochem Pharmacol; 1979 May; 28(10):1609-14. PubMed ID: 38792
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD; Toon S; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):312-9. PubMed ID: 3621786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lauric acid hydroxylation in human liver and kidney cortex microsomes.
    Okita RT; Jakobsson SW; Prough RA; Masters BS
    Biochem Pharmacol; 1979 Dec; 28(23):3385-90. PubMed ID: 533546
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereoselective drug distribution and anticoagulant potency of the enantiomers of phenprocoumon in rats.
    Schmidt W; Jähnchen E
    J Pharm Pharmacol; 1977 May; 29(5):266-71. PubMed ID: 17688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro.
    Uehleke H; Hellmer KH; Tabarelli-Poplawski S
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(1):39-52. PubMed ID: 4147966
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
    Vyas KP; Kari PH; Prakash SR; Duggan DE
    Drug Metab Dispos; 1990; 18(2):218-22. PubMed ID: 1971576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial models of mammalian metabolism: production of novel alpha-diketone metabolites of warfarin and phenprocoumon using Aspergillus niger.
    Rizzo JD; Davis PJ
    Xenobiotica; 1988 Dec; 18(12):1425-37. PubMed ID: 3245234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dizepam metabolism in human foetal and adult liver.
    Ackermann E; Richter K
    Eur J Clin Pharmacol; 1977; 11(1):43-9. PubMed ID: 832657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.